Carrie C Strom - Net Worth and Insider Trading

Carrie C Strom Net Worth

The estimated net worth of Carrie C Strom is at least $6 Million dollars as of 2024-04-27. Carrie C Strom is the SVP & PRES GLOBAL ALLERG AESTH of AbbVie Inc and owns about 37,921 shares of AbbVie Inc (ABBV) stock worth over $6 Million. Details can be seen in Carrie C Strom's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Carrie C Strom has not made any transactions after 2023-02-21 and currently still holds the listed stock(s).

Transaction Summary of Carrie C Strom

To

Carrie C Strom Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Carrie C Strom owns 1 companies in total, including AbbVie Inc (ABBV) .

Click here to see the complete history of Carrie C Strom’s form 4 insider trades.

Insider Ownership Summary of Carrie C Strom

Ticker Comapny Transaction Date Type of Owner
ABBV AbbVie Inc 2023-02-21 SVP & Pres Global Allerg Aesth

Carrie C Strom Latest Holdings Summary

Carrie C Strom currently owns a total of 1 stock. Carrie C Strom owns 37,921 shares of AbbVie Inc (ABBV) as of February 21, 2023, with a value of $6 Million.

Latest Holdings of Carrie C Strom

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ABBV AbbVie Inc 2023-02-21 37,921 159.62 6,052,950

Holding Weightings of Carrie C Strom


Carrie C Strom Form 4 Trading Tracker

According to the SEC Form 4 filings, Carrie C Strom has made a total of 3 transactions in AbbVie Inc (ABBV) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in AbbVie Inc is the sale of 28,541 shares on February 21, 2023, which brought Carrie C Strom around $4 Million.

Insider Trading History of Carrie C Strom

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Carrie C Strom Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Carrie C Strom Ownership Network

Ownership Network List of Carrie C Strom

No Data

Ownership Network Relation of Carrie C Strom


Carrie C Strom Owned Company Details

What does AbbVie Inc do?

Who are the key executives at AbbVie Inc?

Carrie C Strom is the SVP & Pres Global Allerg Aesth of AbbVie Inc. Other key executives at AbbVie Inc include SVP & Enterprise Innovation Nicholas Donoghoe , SVP & US Commercial Operations Jeffrey Ryan Stewart , and EVP & Chief HR Officer Timothy J. Richmond .

AbbVie Inc (ABBV) Insider Trades Summary

Over the past 18 months, Carrie C Strom made no insider transaction in AbbVie Inc (ABBV). Other recent insider transactions involving AbbVie Inc (ABBV) include a net sale of 58,955 shares made by Elaine K. Sorg , a net sale of 46,663 shares made by Perry C Siatis , and a net sale of 114,860 shares made by Azita Saleki-gerhardt .

In summary, during the past 3 months, insiders sold 459,004 shares of AbbVie Inc (ABBV) in total and bought 0 shares, with a net sale of 459,004 shares. During the past 18 months, 840,580 shares of AbbVie Inc (ABBV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 840,580 shares.

AbbVie Inc (ABBV)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

AbbVie Inc Insider Transactions

No Available Data

Carrie C Strom Mailing Address

Above is the net worth, insider trading, and ownership report for Carrie C Strom. You might contact Carrie C Strom via mailing address: 1 N. Waukegan Road, North Chicago Il 60064.

Discussions on Carrie C Strom

No discussions yet.